SECTOR GAMMA AS Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001475373

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 41 positions · Total reported value $484.96M · Top-10 concentration 48.7% · Updated 2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

Turnover: 63.8% · 7 new · 17 cut · 6 exited

Active Share (vs S&P 500): 96.9% · vs QQQ: 99.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +4.8% · vs SPY +2.7% · Prev Value $460.97M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +4.4% · vs SPY +2.3% · Latest Value $484.96M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, SECTOR GAMMA AS disclosed 41 equity positions with a combined reported value of $484.96M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were BMY ($38.25M), PFE ($36.14M), MDT ($32.90M). By sector, the heaviest allocations are Health Care 86.3%, Industrials 10.3%. Versus the prior quarter, allocation shifted toward Industrials (+0.6pp) and away from Other (-0.9pp).

Versus the prior quarter, SECTOR GAMMA AS opened 7 new positions, trimmed 17 and fully exited 6, a turnover rate of 63.8% of positions. The portfolio's overlap with the prior quarter was 72% of names.

The largest new positions opened in Q3 2026 were DHR ($14.04M), UNH ($7.34M), AZN ($7.27M).

Of the 6 positions fully exited versus the prior quarter, the largest were TMO ($16.84M), AMGN ($9.52M), DXCM ($6.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • DHR DANAHER CORP DEL · $14.04M
  • UNH UNITEDHEALTH GROUP INC · $7.34M
  • AZN ASTRAZENECA PLC · $7.27M
  • HCA HCA HEALTHCARE INC · $4.27M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $3.28M
  • DNLI DENALI THERAPEUTICS INC · $2.85M
  • VRDN VIRIDIAN THERAPEUTICS INC · $1.75M

Fully Exited (vs previous quarter)

  • TMO THERMO FISHER SCIENTIFIC INC · prev qtr: $16.84M
  • AMGN AMGEN INC · prev qtr: $9.52M
  • DXCM DEXCOM INC · prev qtr: $6.88M
  • CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $4.29M
  • OGN ORGANON & CO · prev qtr: $3.67M
  • NTLA INTELLIA THERAPEUTICS INC · prev qtr: $3.13M

Insider Transactions (Form 4)

Latest SECTOR GAMMA AS buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sector Gamma AS files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 40 positions worth $460.97M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 40 positions · $460.97M reported value (Q2 2026)
  • Top 10 holdings = 48.4% of reported value
  • Largest position: BMY (BRISTOL-MYERS SQUIBB CO) at 9.1%
  • Average position size: $11.52M

Sector Tilt

  • Health Care 85.9%
  • Industrials 9.7%
  • Consumer Staples 3.5%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 6 new, 19 added, 11 reduced, 8 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is tactically reducing exposure to large-cap pharma (BMY, MRK, INCY, ELV) while adding to diversified healthcare (MDT, GEHC, BIIB) and consumer staples (CVS), suggesting a preference for stable, non-cyclical healthcare and defensive sectors. 2. Key moves: - Added: PFE (+26.2% shares), MDT (+8.2%), CVS (+26.5%), GEHC (+23.6%), BIIB (+23.0%). - Reduced: BMY (-15.6%), MRK (-11.0%), INCY (-9.2%), ELV (-9.6%), BMRN (-0.6%). 3. Portfolio structure: Active, with a strong Health Care bias (90% of top-10), moderate risk appetite (41 positions, concentrated top-10). 4. Per-holding one-liner: - BMY: Pharma (unverified). - PFE: Pharma (unverified). - MDT: Medical devices (unverified). - MRK: Pharma (unverified). - INCY: Biotech (unverified). - BMRN: Biotech (unverified). - CVS: Healthcare retail (unverified). - GEHC: Medtech (unverified). - ELV: Managed care (unverified). - BIIB: Biotech (unverified). 5. Style summary: The fund tactically rotated from large-cap pharma to diversified healthcare and consumer staples, favoring stability over pure pharma exposure.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-14 23:05

Sector Allocation

Health Care 86.3%
Industrials 10.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 612.96K $38.25M 7.89%
7.89%
Reduce
2 1.27M $36.14M 7.45%
7.45%
Add
3 381.25K $32.90M 6.78%
6.78%
Add
4 193.04K $28.05M 5.78%
5.78%
Reduce
5 155.10K $18.82M 3.88%
3.88%
Reduce
6 293.29K $17.60M 3.63%
3.63%
Reduce
7 196.57K $16.84M 3.47%
3.47%
Add
8 256.91K $16.79M 3.46%
3.46%
Add
9 40.23K $15.64M 3.23%
3.23%
Reduce
10 66.65K $15.05M 3.10%
3.10%
Add
11 330.04K $14.74M 3.04%
3.04%
Add
12 217.35K $14.07M 2.90%
2.90%
Add
13 63.38K $14.04M 2.90%
2.90%
New
14 141.74K $14.01M 2.89%
2.89%
Reduce
15 75.63K $13.54M 2.79%
2.79%
Reduce
16 308.13K $13.45M 2.77%
2.77%
Add
17 33.35K $12.60M 2.60%
2.60%
Hold
18 131.48K $11.68M 2.41%
2.41%
Reduce
19 42.28K $11.37M 2.34%
2.34%
Reduce
20 14.18K $10.76M 2.22%
2.22%
Reduce
21 231.17K $10.12M 2.09%
2.09%
Reduce
22 31.02K $9.56M 1.97%
1.97%
Add
23 606.09K $9.12M 1.88%
1.88%
Reduce
24 40.30K $8.97M 1.85%
1.85%
Reduce
25 142.41K $8.85M 1.82%
1.82%
Reduce
26 20.00K $7.34M 1.51%
1.51%
New
27 45.05K $7.27M 1.50%
1.50%
New
28 112.00K $7.26M 1.50%
1.50%
Add
29 388.47K $5.76M 1.19%
1.19%
Reduce
30 60.40K $5.21M 1.07%
1.07%
Hold
31 433.01K $4.64M 0.96%
0.96%
Hold
32 241.74K $4.54M 0.94%
0.94%
Hold
33 267.09K $4.36M 0.90%
0.90%
Hold
34 10.00K $4.27M 0.88%
0.88%
New
35 18.30K $4.17M 0.86%
0.86%
Reduce
36 68.00K $4.00M 0.83%
0.83%
Reduce
37 6.50K $3.28M 0.68%
0.68%
New
38 45.00K $2.97M 0.61%
0.61%
Hold
39 137.72K $2.85M 0.59%
0.59%
New
40 686.84K $2.35M 0.48%
0.48%
Hold
41 84.87K $1.75M 0.36%
0.36%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 80% R 80% F1 80% (modelled on 2026-Q2; 8/10 hit)

Low-confidence forecast This fund replaces about 22% of its Top-10 each quarter and backtests at F1 78% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 78% · recall 78% · F1 78% · avg rank error 2.2 · Top-10 turnover 22%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% MDT · PFE · GILD · BIIB · INCY · GEHC · CVS · ZBH · BMY · CNC MDT · PFE · BMY · CVS · CAH · GILD · ELV · ZBH · INCY · BAX
2024-Q2 80% 80% 80% MDT · PFE · CVS · BMY · CAH · ELV · GILD · ZBH · BAX · INCY GILD · PFE · BMY · MDT · ELV · CVS · INCY · CAH · BIIB · AMGN
2024-Q3 70% 70% 70% GILD · PFE · BMY · MDT · ELV · CVS · INCY · CAH · BIIB · AMGN BMY · MDT · GILD · PFE · CVS · BDX · INCY · BAX · ELV · BMRN
2024-Q4 70% 70% 70% BMY · MDT · GILD · PFE · CVS · BDX · INCY · BAX · BMRN · ELV PFE · MDT · BMY · GILD · BDX · ZBH · BMRN · INCY · AMGN · JNJ
2025-Q1 70% 70% 70% PFE · MDT · BMY · BDX · GILD · BMRN · ZBH · INCY · AMGN · CNC BMY · PFE · BDX · MDT · AMGN · JNJ · GILD · CVS · ZBH · ELV
2025-Q2 70% 70% 70% BMY · PFE · AMGN · BDX · MDT · JNJ · GILD · CVS · ELV · ZBH PFE · MDT · BMY · BDX · MRK · GILD · INCY · AMGN · IONS · CVS
2025-Q3 100% 100% 100% PFE · MDT · BMY · BDX · MRK · INCY · GILD · AMGN · IONS · CVS PFE · MDT · MRK · BMY · BDX · IONS · INCY · AMGN · GILD · CVS
2025-Q4 100% 100% 100% PFE · MRK · MDT · BMY · BDX · INCY · IONS · AMGN · GILD · BIIB BMY · MRK · MDT · BDX · GILD · INCY · PFE · AMGN · BIIB · IONS
2026-Q1 80% 80% 80% BMY · MRK · BDX · MDT · GILD · INCY · PFE · AMGN · BIIB · CVS BMY · MRK · PFE · MDT · INCY · AMGN · BIIB · ZBH · BMRN · BDX
2026-Q2 70% 70% 70% BMY · MRK · PFE · MDT · INCY · BIIB · AMGN · ZBH · ELV · BMRN BMY · MRK · MDT · PFE · INCY · ELV · BMRN · TMO · CVS · IQV
2026-Q3 ★ 80% 80% 80% BMY · MDT · MRK · PFE · INCY · TMO · ELV · BMRN · IQV · CVS BMY · PFE · MDT · MRK · INCY · BMRN · CVS · GEHC · ELV · BIIB

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-12. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-12 Trading days31 Holdings19 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-12, and will update as prices arrive.

Portfolio return+9.87%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+21.02%vs benchmark
Barra annualised vol18.2%Model estimate
Realised vol19.1%Annualised in window
Weighted beta0.26Raw exposure
Factor / specific risk82% / 18%Share of variance
Top-10 concentration75.8%Of reported value
Portfolio value (start = 100)77.886.695.4104.2113.110-0110-2211-12SECTOR GAMMA ASQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+9.87%Disclosed long book
QQQ synthetic benchmark-11.15%Liquidity-weighted constituents
Model universe, equal weight+2.04%Opportunity-cost reference
Excess return+21.02%Portfolio − benchmark
Arithmetic return sum+9.64%Difference vs compounded is the cross term
Weighted raw beta0.26Weighted holding betas
Realised volatility (annualised)19.11%Daily returns in window
Barra model volatility (annualised)18.20%Factor + specific
Factor share of variance82.1%Barra factors
Specific share of variance17.9%Stock residuals
Reported value$268.6M13F long US equity

2. Return attribution

The +9.64% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -0.21% -2.2%
Momentum & Growth 3 -0.30% -3.1%
Volatility & Tail Risk 7 +2.59% 26.8%
Industry 12 +9.27% 96.1%
Specific 1 -1.70% -17.6%
Return attribution (style + industry, %)-8.7-4.4+0.0+4.4+8.7Size+0.12Mid Cap+0.30Industrials+0.31Short-term Reversal+0.32Turnover-0.55Momentum-0.56Residual Volatility+0.78Leverage (Downside Vol)+0.82Consumer Staples+0.91Skewness-1.79Kurtosis+2.16Beta-3.07Historical Volatility+3.75Health Care+8.06
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.85 +9.47% +8.06% 83.6%
Historical Volatility Style -0.38 -9.82% +3.75% 38.9%
Kurtosis Style +0.35 +6.17% +2.16% 22.4%
Consumer Staples Industry +0.06 +14.46% +0.91% 9.4%
Leverage (Downside Vol) Style -0.27 -3.05% +0.82% 8.5%
Residual Volatility Style +0.36 +2.15% +0.78% 8.1%
Short-term Reversal Style +0.28 +1.12% +0.32% 3.3%
Industrials Industry +0.09 +3.55% +0.31% 3.2%
Mid Cap Style -0.16 -1.92% +0.30% 3.1%
Size Style -0.06 -1.93% +0.12% 1.2%
Growth Style -0.04 +1.50% -0.05% -0.6%
Max Drawdown Style +0.07 -1.01% -0.07% -0.7%
Amihud Illiquidity Style -0.35 +0.30% -0.10% -1.1%
Turnover Style +0.13 -4.35% -0.55% -5.7%
Momentum Style +0.17 -3.32% -0.56% -5.9%
Specific Specific — — -1.70% -17.6%
Skewness Style +0.37 -4.77% -1.79% -18.5%
Beta Style -0.62 +4.92% -3.07% -31.8%

3. Risk attribution

Annualised volatility is 18.20%; factor risk explains 82.1% of variance and specific risk 17.9%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-64.6-32.3+0.0+32.3+64.6Residual Volatility-4.18Max Drawdown-0.85Non-linear Size+1.25Consumer Staples+1.25Industrials+1.34Liquidity+1.45Kurtosis+1.63Leverage (Downside Vol)+1.76Momentum+1.78Short-term Reversal+2.46Historical Volatility+5.62Beta+6.58Specific+17.95Health Care+59.85
Factor Type Exposure Share of variance Vol contribution Share of vol
Health Care Industry +0.85 59.9% +10.89% 10.9%
Specific Specific — 17.9% +3.27% 3.3%
Beta Style -0.62 6.6% +1.20% 1.2%
Historical Volatility Style -0.38 5.6% +1.02% 1.0%
Short-term Reversal Style +0.28 2.5% +0.45% 0.5%
Momentum Style +0.17 1.8% +0.32% 0.3%
Leverage (Downside Vol) Style -0.27 1.8% +0.32% 0.3%
Kurtosis Style +0.35 1.6% +0.30% 0.3%
Liquidity Style -0.24 1.4% +0.26% 0.3%
Industrials Industry +0.09 1.3% +0.24% 0.2%
Non-linear Size Style -0.34 1.2% +0.23% 0.2%
Consumer Staples Industry +0.06 1.2% +0.23% 0.2%
Amihud Illiquidity Style -0.35 0.6% +0.12% 0.1%
Skewness Style +0.37 0.5% +0.09% 0.1%
Size Style -0.06 0.4% +0.08% 0.1%
Turnover Style +0.13 0.3% +0.06% 0.1%
Mid Cap Style -0.16 0.2% +0.04% 0.0%
Max Drawdown Style +0.07 -0.8% -0.16% -0.2%
Residual Volatility Style +0.36 -4.2% -0.76% -0.8%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.62.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.06 +2.10 -2.16
Non-linear Size -0.34 +1.68 -2.02
Mid Cap -0.16 +0.13 -0.28
Beta -0.62 +1.29 -1.92
Momentum +0.17 +0.72 -0.55
Short-term Reversal +0.28 -0.64 +0.93
Residual Volatility +0.36 -0.40 +0.77
Historical Volatility -0.38 +0.86 -1.24
Liquidity -0.24 +0.11 -0.35
Amihud Illiquidity -0.35 +1.16 -1.50
Turnover +0.13 +0.21 -0.08
Growth -0.04 +0.58 -0.62
Leverage (Downside Vol) -0.27 +0.14 -0.41
Skewness +0.37 +0.24 +0.14
Kurtosis +0.35 +0.21 +0.13
Max Drawdown +0.07 -0.08 +0.15

5. Industry allocation & Brinson

Industry allocation (weight, %)-8.517.042.668.193.6Information TechnologyCommunication ServicesUtilitiesConsumer DiscretionaryConsumer StaplesIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -16.67% +4.61% +12.27% -12.27% +12.27%
Health Care 85.1% 1.7% +10.45% +9.50% +16.59% +0.02% +0.79% +8.73%
Communication Services 0.0% 2.6% +0.00% -12.15% +0.05% +0.32% -0.32% +0.32%
Consumer Staples 6.3% 0.8% +4.47% +15.33% +1.40% -0.09% -0.59% +0.15%
Utilities 0.0% 0.8% +0.00% +10.14% -0.16% -0.08% +0.08% -0.08%
Industrials 8.6% 11.1% +5.54% +7.87% -0.45% -0.26% +0.06% -0.40%
Consumer Discretionary 0.0% 8.8% +0.00% +5.93% -1.44% -0.52% +0.52% -0.52%
Total +20.51% +11.62% -11.69% +20.44%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
BMY BRISTOL-MYERS SQUIBB CO Health Care 14.24% +1.86% +0.27% Reduce
MDT MEDTRONIC PLC Health Care 12.25% +17.75% +2.17% Add
MRK MERCK & CO Health Care 10.44% +1.29% +0.13% Reduce
CVS CVS HEALTH CORP Consumer Staples 6.27% +4.47% +0.28% Add
GEHC GE HEALTHCARE TECHNOLOGIES I Health Care 6.25% +26.36% +1.65% Add
ELV ELEVANCE HEALTH INC FORMERLY Health Care 5.82% +10.46% +0.61% Reduce
DHR DANAHER CORP DEL Industrials 5.23% +6.21% +0.33% New
ABT ABBOTT LABORATORIES Health Care 5.21% +10.58% +0.55% Reduce
BDX BECTON DICKINSON & CO Health Care 5.04% +19.84% +1.00% Reduce
BSX BOSTON SCIENTIFIC CORP Health Care 5.01% +3.39% +0.17% Add
IQV IQVIA HLDGS INC Health Care 4.23% +2.11% +0.09% Reduce
REGN REGENERON PHARMACEUTICALS Health Care 4.00% +26.53% +1.06% Reduce
AVTR AVANTOR INC Industrials 3.40% +4.52% +0.15% Reduce
CNC CENTENE CORP DEL Health Care 3.29% +13.46% +0.44% Reduce
UNH UNITEDHEALTH GROUP INC Health Care 2.73% +9.77% +0.27% New
AZN ASTRAZENECA PLC Health Care 2.71% +14.87% +0.40% New
HCA HCA HEALTHCARE INC Health Care 1.59% +18.58% +0.29% New
MDGL MADRIGAL PHARMACEUTICALS INC Health Care 1.22% -14.07% -0.17% New
DNLI DENALI THERAPEUTICS INC Health Care 1.06% -4.55% -0.05% New
Contribution rank Symbol Sector Weight Return Contribution
1 MDT Health Care 12.25% +17.75% +2.17%
2 GEHC Health Care 6.25% +26.36% +1.65%
3 REGN Health Care 4.00% +26.53% +1.06%
4 BDX Health Care 5.04% +19.84% +1.00%
5 ELV Health Care 5.82% +10.46% +0.61%
6 ABT Health Care 5.21% +10.58% +0.55%
7 CNC Health Care 3.29% +13.46% +0.44%
8 AZN Health Care 2.71% +14.87% +0.40%
9 AVTR Industrials 3.40% +4.52% +0.15%
10 MRK Health Care 10.44% +1.29% +0.13%
11 IQV Health Care 4.23% +2.11% +0.09%
12 DNLI Health Care 1.06% -4.55% -0.05%
13 MDGL Health Care 1.22% -14.07% -0.17%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-12 (31 trading days), the reported portfolio returned +9.87%, versus -11.15% for the QQQ synthetic benchmark — an excess of +21.02%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +8.06%, Historical Volatility +3.75%, Kurtosis +2.16%; the largest drags came from Beta -3.07%, Skewness -1.79%, Momentum -0.56%. Specific (stock-level) return contributed -1.70%.
  3. Risk attribution: Barra model volatility is 18.20% annualised; factor risk explains 82% of variance and specific risk 18%. The largest factor risk sources are Health Care 59.9%, Beta 6.6%, Historical Volatility 5.6%.
  4. Style tilt: size -0.06, momentum +0.17, volatility -0.38, liquidity -0.24; the weighted raw beta is 0.26. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+83.4 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +20.51%, selection +11.62% and interaction -11.69%.
  6. Concentration: the top-10 positions are 75.8% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did SECTOR GAMMA AS buy in 2026-Q3?

In its 2026-Q3 13F filing, SECTOR GAMMA AS reported 41 equity positions worth $484.96M in aggregate; its largest disclosed positions were BMY ($38.25M), PFE ($36.14M), MDT ($32.90M).

How large is SECTOR GAMMA AS's portfolio?

SECTOR GAMMA AS reported $484.96M of long equity holdings across 41 positions as of 2026-Q3. Top-10 holdings account for 48.7% of reported value.

What is SECTOR GAMMA AS's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sector-gamma-as/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →